Excess Adiposity Linked to Vertebral Fracture Risk in Early Breast Cancer
Aromatase inhibitors serve as a standard adjuvant treatment for hormone receptor-positive early breast cancer, but the therapy is known to accelerate bone loss and increase fracture risk. Excess Adiposity Linked … Read More